We are live on ! Find out more
MAM

Mastrapasqua Asset Management Portfolio holdings

AUM $853M
1-Year Est. Return 37.36%
This Fund
S&P 500
This Quarter Est. Return
+4.8%
1 Year Est. Return
+37.36%
3 Year Est. Return
+54.87%
5 Year Est. Return
+127.67%
10 Year Est. Return
AUM
$435M
AUM Growth
+$9.07M
Cap. Flow
-$8.39M
Cap. Flow %
-1.93%
Top 10 Hldgs %
23.16%
Holding
160
New
9
Increased
75
Reduced
56
Closed
12

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$5.82M
2
VZ icon
Verizon
VZ
+$5.56M
3
DOX icon
Amdocs
DOX
+$4.21M
4
RTN
Raytheon Company
RTN
+$3.71M
5
GILD icon
Gilead Sciences
GILD
+$2.11M

Sector Composition

Rank Sector Weight
1 Technology 21.23%
2 Industrials 16.21%
3 Healthcare 13.97%
4 Consumer Discretionary 11%
5 Materials 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$14.4M 3.32%
621,184
-14,136
-2% -$301K
SBUX icon
2
Starbucks
SBUX
$118B
$10.8M 2.47%
277,978
+28,412
+11% +$1.03M
MSFT icon
3
Microsoft
MSFT
$2.84T
$10.6M 2.44%
254,440
-4,679
-2% -$189K
QCOM icon
4
Qualcomm
QCOM
$176B
$9.7M 2.23%
122,517
-1,620
-1% -$129K
MON
5
DELISTED
Monsanto Co
MON
$9.48M 2.18%
76,015
-1,211
-2% -$142K
GILD icon
6
Gilead Sciences
GILD
$161B
$9.48M 2.18%
114,321
+27,111
+31% +$2.11M
CVS icon
7
CVS Health
CVS
$137B
$9.37M 2.16%
124,352
-2,685
-2% -$203K
SLB icon
8
SLB Ltd
SLB
$77.8B
$9.1M 2.09%
77,127
-1,233
-2% -$127K
AMGN icon
9
Amgen
AMGN
$203B
$9.08M 2.09%
76,726
+1,680
+2% +$194K
GOOG icon
10
Alphabet (Google) Class C
GOOG
$3.9T
$8.68M 2%
300,062
-1,183
-0.4% -$32.1K
HOT
11
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$8.57M 1.97%
106,046
-1,662
-2% -$131K
DIS icon
12
Walt Disney
DIS
$165B
$8.53M 1.96%
99,534
-17,446
-15% -$1.42M
MCHP icon
13
Microchip Technology
MCHP
$42.8B
$8.44M 1.94%
345,838
-2,352
-0.7% -$56.1K
NOV icon
14
NOV
NOV
$7.45B
$8.34M 1.92%
101,211
-13,748
-12% -$1.02M
HD icon
15
Home Depot
HD
$332B
$8.28M 1.91%
102,326
-1,902
-2% -$150K
PX
16
DELISTED
Praxair Inc
PX
$8.17M 1.88%
61,523
-1,090
-2% -$143K
INTC icon
17
Intel
INTC
$466B
$7.88M 1.81%
255,159
-3,730
-1% -$102K
PH icon
18
Parker-Hannifin
PH
$125B
$7.45M 1.71%
59,248
-3
-0% -$374
NKE icon
19
Nike
NKE
$61.9B
$7.42M 1.71%
191,404
-3,572
-2% -$133K
ECL icon
20
Ecolab
ECL
$75.6B
$7.2M 1.66%
64,700
-616
-0.9% -$66K
AGN
21
DELISTED
Allergan plc
AGN
$7.18M 1.65%
32,180
-3,752
-10% -$777K
RTX icon
22
RTX Corp
RTX
$287B
$6.87M 1.58%
94,485
-1,008
-1% -$74.2K
V icon
23
Visa
V
$677B
$6.76M 1.55%
128,316
-24,880
-16% -$1.3M
KLAC icon
24
KLA
KLAC
$275B
$6.74M 1.55%
927,360
+126,400
+16% +$839K
DD
25
DELISTED
Du Pont De Nemours E I
DD
$6.72M 1.55%
108,109
+730
+0.7% +$46.9K

Similar funds

Mastrapasqua Asset Management's Q2 2014 Portfolio in Review

As of Q2 2014, Mastrapasqua Asset Management held 160 positions worth $435M, up 2.1% from $426M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Mastrapasqua Asset Management's Q2 2014 filing shows 9 new, 75 increased, 56 reduced and 12 closed positions. Its largest new stake was Oracle: 141,555 shares worth $5.74M. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $6.27M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.

  • Mastrapasqua Asset Management's largest Q2 2014 buy was Oracle: 141,555 shares worth $5.74M.
  • Mastrapasqua Asset Management added most to Verizon in Q2 2014, an estimated $5.56M increase.
  • Mastrapasqua Asset Management's biggest Q2 2014 reduction was Bristol-Myers Squibb, cutting an estimated $5.57M.
  • Mastrapasqua Asset Management fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2014, selling an estimated $6.27M.
  • Mastrapasqua Asset Management's ten largest holdings make up 23% of its $435M portfolio in Q2 2014.
  • Mastrapasqua Asset Management opened 9 new positions and closed 12 in Q2 2014.
  • Mastrapasqua Asset Management's portfolio value rose 2.1% quarter-over-quarter to $435M.

Based on Mastrapasqua Asset Management's 13F filing for Q2 2014, filed 18 Aug 2014.